查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1916495

全球動物藥品市場：市場規模、份額、成長率、產業分析、按類型、應用和地區劃分的考量因素以及未來預測（2026-2034）

Veterinary Drugs Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 180 Pages | 商品交期: 請詢問到貨日

價格

動物藥品市場成長驅動因素

全球動物藥品市場在保護動物健康、確保食品安全和預防人畜共通傳染病傳播方面發揮著至關重要的作用。根據報告的預測，到2025年，全球動物藥品市場規模預計將達到305.4億美元。在動物疾病發病率上升、寵物飼養量增加以及對動物性蛋白質需求成長的推動下，預計到2026年，該市場規模將達到322億美元。在長期預測期內，伴侶動物和牲畜市場預計都將保持穩定持續成長，到2034年將達到530.5億美元。

動物藥品用於預防、診斷、緩解和治療動物疾病，並維持動物的最佳生理功能。抗感染藥、驅蟲藥、抗發炎藥物和其他治療藥物可解決多種動物健康問題，包括牛呼吸道疾病、口蹄疫、禽流感、乳房炎、寄生蟲病和皮膚病。全球人畜共通傳染病和傳染病發病率的不斷上升，進一步凸顯了有效動物治療藥物的重要性。

市場動態

獸藥市場的主要驅動因素是牲畜和伴侶動物獸醫疾病的日益增加。疾病發生率的上升推動了對預防和治療藥物的需求，尤其是在牲畜數量多、密集養殖的地區。各國政府和動物衛生組織積極支持疫苗接種計劃、疾病監測和宣傳活動，進一步促進了藥物的使用。

另一個重要的成長因素是寵物主人數量的增加以及伴侶動物的人性化。寵物主人將動物視為家庭成員，並願意投資先進的獸醫護理、常規藥物和預防性治療。這一趨勢正在推動對高端動物藥品的需求，包括生物製劑、單株抗體和疼痛管理療法。

然而，非法和假冒動物藥品阻礙了市場發展。未經許可的產品加劇了抗菌素抗藥性，並削弱了人們對正規藥品的信任，對動物健康、食品安全和公共衛生構成威脅。監管機構正在持續加強執法力度，以遏制非法藥品的流通。

市場機會與挑戰

全球寵物數量的成長和可支配收入的增加為動物藥品生產商提供了巨大的機會。日常獸醫護理、疫苗接種和慢性病管理的支出增加，催生了對創新和專業化藥品的需求。新興國家獸醫服務的擴張也進一步支撐了市場潛力。

同時，市場也面臨與抗菌素抗藥性（AMR）相關的挑戰。動物抗生素的過度使用和濫用導致抗藥性加速發展，促使監管部門推出更嚴格的指導方針並減少抗生素的使用。雖然這些措施有助於提高長期可持續性，但可能會限制某些藥物類別的短期成長。

市場趨勢

影響動物保健市場的一大趨勢是先進療法的興起，包括基因療法、單株抗體和細胞療法。這些創新技術能夠針對複雜的動物疾病進行標靶、個人化治療，同時減少副作用。另一個值得關注的趨勢是向永續獸醫學的轉變，製造商專注於環境友善配方，並減少驅蟲產品對生態環境的影響。

依細分市場分析

按產品類型劃分，驅蟲藥佔據市場主導地位，由於家畜和伴侶動物寄生蟲感染的普遍存在，驅蟲藥佔據了最大的市場份額。抗發炎藥物維持了第二大市場份額，這主要得益於寵物骨關節炎和術後疼痛管理需求的成長。抗感染藥物持續發揮重要作用，尤其是在畜牧疾病管理方面。

按動物類型劃分，伴侶動物市場佔據主導地位，這得益於寵物主人數量的增長、醫療保健支出的增加以及預防醫學意識的提高。畜牧業也維持了強勁的市場份額，這主要歸功於全球對肉類、乳製品和水產養殖產品需求的成長。

按給藥途徑劃分，口服獸藥因其給藥方便且寵物主人依從性高而佔據了大部分市場份額。同時，因其起效迅速而備受青睞的注射劑型需求也在不斷增長，而外用和氣霧劑型則繼續保持著一定的應用前景。

按分銷管道劃分，獸醫診所佔據了最大的市場份額，這得益於其先進的治療設施和專業獸醫的聚集。診所和藥局持續擴大常規獸藥的供應範圍。

區域展望

北美將在2025年以38.57%的市場份額引領獸藥市場，這得益於其較高的寵物擁有率、先進的獸醫基礎設施以及積極的研發活動。歐洲市場持續穩定成長，這主要得益於寵物擁有量的增加以及監管機構對合理用藥的重視。亞太地區正崛起為高成長地區，這得益於畜牧業的擴張、可支配收入的提高以及政府支持的動物健康計畫。拉丁美洲以及中東和非洲地區由於畜牧業的擴張和對動物性蛋白質需求的增加，呈現溫和成長態勢。

關鍵成長因素包括人們對動物保健意識的提高、政府主導的疾病控制措施以及伴侶動物日益人性化，這些因素推動了對先進、高品質治療的需求。然而，抗菌素抗藥性和非法獸藥的流通等挑戰正在推動更嚴格的監管和更合理的用藥。從區域來看，北美保持領先地位，而亞太地區則憑藉畜牧業生產的擴張和收入的成長，成為高成長市場。總體而言，全球動物保健市場預計將保持韌性，以創新為驅動，對動物健康和公共衛生都至關重要，這與本報告涵蓋的年份（2025年、2026年和2034年）密切相關。

目錄

第一章：引言

第二章：執行摘要

第三章：市場動態

  • 市場驅動因素
  • 市場限制因素
  • 市場機遇
  • 市場趨勢

第四章：關鍵考慮因素

  • 動物疾病概覽：依主要國家及地區劃分（2026年）
  • 在開發產品分析
  • 監管狀況：按主要國家和地區劃分（2026 年）
  • 價格分析
  • 寵物擁有量統計資料：按主要國家和地區劃分（2026 年）
  • 新療法與在研療法概述
  • 各種動物疾病治療方案概述
  • 主要公司新產品發布
  • 主要趨勢：併購、聯盟等
  • 新冠疫情對全球動物保健市場的影響

第五章：全球動物保健市場分析、洞察與預測（2021-2034 年）

  • 市場分析、洞察與預測：依產品分類
    • 抗感染藥
    • 抗發炎藥
    • 驅蟲藥
    • 其他
  • 市場分析、洞察與預測：依動物種類分類類型
    • 伴侶動物
      • 貓
      • 狗
      • 鳥類
      • 其他
    • 牲畜
      • 家禽
      • 豬
      • 牛
      • 其他
  • 市場分析、洞察與預測：依給藥途徑
    • 口服
    • 注射
    • 外用
    • 氣霧劑
  • 市場分析、洞察與預測：依銷售管道
    • 獸醫院
    • 獸醫診所
    • 藥局和藥局
    • 其他
  • 市場分析、洞察與預測：按地區
    • 北部美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲

第六章 北美動物保健市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 美國
    • 加拿大

第七章 歐洲動物保健市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 斯堪的納維亞半島
    • 歐洲其他地區

第八章 亞太地區動物保健市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 中國
    • 日本
    • 印度
    • 澳大利亞
    • 東南亞
    • 亞太其他地區

第九章：拉丁美洲動物保健市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 巴西
    • 墨西哥
    • 其他拉丁美洲國家

第十章：中東與非洲動物保健市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 海灣合作委員會
    • 南非
    • 中東其他地區非洲

第十一章 競爭分析

  • 世界市場佔有率分析(2026年)
  • 企業簡介
    • Zoetis Services LLC
    • Merck &Co., Inc.
    • Elanco Animal Health Incorporated
    • Boehringer Ingelheim International GmbH.
    • Ceva
    • Vetoquinol
    • Dechra Pharmaceuticals Limited
    • Virbac Corporation
Product Code: FBI100171

Growth Factors of veterinary drugs Market

The global veterinary drugs market plays a vital role in safeguarding animal health, ensuring food security, and controlling zoonotic disease transmission. According to the report timeline, the global veterinary drugs market size was valued at USD 30.54 billion in 2025. Supported by rising animal disease prevalence, expanding pet ownership, and growing demand for animal-derived protein, the market is projected to grow to USD 32.20 billion in 2026. Over the long-term forecast period, the market is expected to reach USD 53.05 billion by 2034, reflecting steady and sustained growth across both companion and livestock animal segments.

Veterinary drugs are used to prevent, diagnose, mitigate, and treat diseases in animals while supporting optimal physiological functions. These drugs include anti-infectives, parasiticides, anti-inflammatory agents, and other therapeutic categories that address widespread animal health issues such as bovine respiratory disease, foot-and-mouth disease, avian influenza, mastitis, parasitic infestations, and dermatological disorders. The rising frequency of zoonotic and infectious diseases globally continues to reinforce the importance of effective veterinary therapeutics.

Market Dynamics

A major driver of the veterinary drugs market is the rising prevalence of veterinary diseases across livestock and companion animals. Increased disease incidence has led to higher demand for preventive and therapeutic treatments, especially in regions with large livestock populations and dense animal farming practices. Governments and animal health organizations are actively supporting vaccination programs, disease surveillance, and awareness initiatives, further boosting drug adoption.

Another significant growth driver is the increase in pet ownership and humanization of companion animals. Pet owners increasingly view animals as family members and are willing to invest in advanced veterinary care, routine medications, and preventive treatments. This trend has expanded demand for premium veterinary drugs, including biologics, monoclonal antibodies, and pain management therapies.

However, the market faces restraints due to the presence of illegal and counterfeit veterinary medicines. Unauthorized products pose risks to animal health, food safety, and public health by contributing to antimicrobial resistance and undermining trust in regulated pharmaceuticals. Regulatory bodies continue to intensify enforcement efforts to curb illegal drug circulation.

Market Opportunities and Challenges

The growing global pet population and rising disposable income present strong opportunities for veterinary drug manufacturers. Increased spending on routine veterinary care, vaccinations, and chronic disease management is creating demand for innovative and specialized drugs. Expansion of veterinary services in emerging economies further supports market potential.

Conversely, the market faces challenges related to antimicrobial resistance (AMR). Overuse and misuse of antibiotics in animals have accelerated resistance development, prompting stricter regulatory guidelines and reduced antibiotic usage. While these measures improve long-term sustainability, they may limit short-term growth for certain drug classes.

Market Trends

A prominent trend shaping the veterinary drugs market is the emergence of advanced therapies, including gene therapy, monoclonal antibodies, and cell-based treatments. These innovations enable targeted and personalized treatment for complex animal diseases while reducing adverse effects. Another notable trend is the shift toward sustainable veterinary practices, with manufacturers focusing on environmentally friendly formulations and reduced ecological impact of parasiticides.

Segmentation Insights

By product type, parasiticides dominated the market, accounting for the largest share due to widespread parasite infestations in livestock and companion animals. Anti-inflammatory drugs held the second-largest share, driven by rising osteoarthritis and post-surgical pain management needs in pets. Anti-infectives continue to play a critical role, particularly in livestock disease control.

By animal type, the companion animal segment dominated the market, supported by increasing pet ownership, higher healthcare spending, and growing awareness of preventive care. The livestock segment also maintained a strong share due to rising global demand for meat, dairy, and aquaculture products.

By route of administration, oral veterinary drugs held the dominant market share, attributed to ease of administration and high owner compliance. Parenteral formulations are gaining traction for their rapid efficacy, while topical and aerosol routes maintain niche usage.

By distribution channel, veterinary hospitals held the largest share, driven by availability of advanced treatment facilities and specialized veterinary professionals. Clinics and pharmacies continue to expand access to routine veterinary medicines.

Regional Outlook

North America dominated the veterinary drugs market with a 38.57% share in 2025, supported by high pet ownership rates, advanced veterinary infrastructure, and strong R&D activity. Europe follows with steady growth driven by rising pet adoption and regulatory emphasis on responsible drug use. Asia Pacific is emerging as a high-growth region due to expanding livestock farming, increasing disposable income, and government-supported animal health programs. Latin America and the Middle East & Africa are witnessing moderate growth, supported by livestock production expansion and rising demand for animal protein.

Competitive Landscape

The veterinary drugs market is moderately consolidated, with key players such as Zoetis Services LLC, Elanco Animal Health Incorporated, Merck Animal Health, Boehringer Ingelheim International GmbH, and Virbac focusing on R&D investment, product innovation, and strategic acquisitions to strengthen their market positions.

Strictly aligned with the report years 2025, 2026, and 2034, the global veterinary drugs market demonstrates stable growth momentum, supported by rising animal health awareness, expanding companion animal care, and continuous advancements in veterinary therapeutics.

Conclusion

The global veterinary drugs market is on a stable growth trajectory, underpinned by rising animal disease prevalence, expanding pet ownership, and increasing demand for safe and high-quality animal protein. Valued at USD 30.54 billion in 2025, the market's growth to USD 32.20 billion in 2026 reflects steady adoption of preventive and therapeutic solutions across companion and livestock animals. The long-term outlook, reaching USD 53.05 billion by 2034, highlights the sustained importance of veterinary pharmaceuticals in animal health management and food security.

Key growth drivers include heightened awareness of animal healthcare, government-backed disease control initiatives, and the growing humanization of companion animals, which is driving demand for advanced and premium therapies. At the same time, challenges such as antimicrobial resistance and the circulation of illegal veterinary medicines are prompting stricter regulations and more responsible drug usage. Regionally, North America maintains leadership, while Asia Pacific is emerging as a high-growth market supported by livestock expansion and rising incomes. Overall, strictly aligned with the report years 2025, 2026, and 2034, the veterinary drugs market is expected to remain resilient, innovation-driven, and critical to both animal and public health worldwide.

Segmentation By Product

  • Anti-infectives
  • Anti-Inflammatory
  • Parasiticides
  • Others

By Animal Type

  • Companion
    • Feline
    • Canine
    • Avian
    • Others
  • Livestock
    • Poultry
    • Porcine
    • Bovine
    • Others

By Route of Administration

  • Oral
  • Parenteral
  • Topical
  • Aerosol

By Distribution Channel

  • Veterinary Hospitals
  • Veterinary Clinics
  • Pharmacies & Drug Stores
  • Others

By Region

  • North America (By Product, Animal, Route of Administration, Distribution Channel, Country/Sub-Region)
    • U.S.
    • Canada
  • Europe (By Product, Animal, Route of Administration, Distribution Channel, Country/Sub-Region)
    • U.K.
    • Germany
    • France
    • Italy
    • Spain
    • Scandinavia
    • Rest of Europe
  • Asia Pacific (By Product, Animal, Route of Administration, Distribution Channel, Country/Sub-Region)
    • Japan
    • China
    • India
    • Australia
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America (By Product, Animal, Route of Administration, Distribution Channel, Country/Sub-Region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Product, Animal, Route of Administration, Distribution Channel, Country/Sub-Region)
    • GCC
    • South Africa
    • Rest of the Middle East & Africa

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Overview of Animal Diseases by Key Countries, By Key Countries/ Region, 2026
  • 4.2. Pipeline Analysis
  • 4.3. Regulatory Scenario By Key Countries/ Region, 2026
  • 4.4. Pricing Analysis
  • 4.5. Pet Ownership Statistics, By Key Countries/ Region, 2026
  • 4.6. Snapshot on the Novel & Upcoming Therapies
  • 4.7. Overview of Treatment Plans for Different Animal Diseases
  • 4.8. New Product Launches, By Key Players
  • 4.9. Key Industry Developments (Mergers, Acquisitions, Partnerships, etc.)
  • 4.10. Impact of COVID-19 on the Global Veterinary Drugs Market

5. Global Veterinary Drugs Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Product
    • 5.1.1. Anti-infectives
    • 5.1.2. Anti-inflammatory
    • 5.1.3. Parasiticides
    • 5.1.4. Others
  • 5.2. Market Analysis, Insights and Forecast - By Animal Type
    • 5.2.1. Companion
      • 5.2.1.1. Feline
      • 5.2.1.2. Canine
      • 5.2.1.3. Avian
      • 5.2.1.4. Others
    • 5.2.2. Livestock
      • 5.2.2.1. Poultry
      • 5.2.2.2. Porcine
      • 5.2.2.3. Bovine
      • 5.2.2.4. Others
  • 5.3. Market Analysis, Insights and Forecast - By Route of Administration
    • 5.3.1. Oral
    • 5.3.2. Parenteral
    • 5.3.3. Topical
    • 5.3.4. Aerosol
  • 5.4. Market Analysis, Insights and Forecast - By Distribution Channel
    • 5.4.1. Veterinary Hospitals
    • 5.4.2. Veterinary Clinics
    • 5.4.3. Pharmacies & Drug Stores
    • 5.4.4. Others
  • 5.5. Market Analysis, Insights and Forecast - Region
    • 5.5.1. North America
    • 5.5.2. Europe
    • 5.5.3. Asia Pacific
    • 5.5.4. Latin America
    • 5.5.5. Middle East & Africa

6. North America Veterinary Drugs Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Product
    • 6.1.1. Anti-infectives
    • 6.1.2. Anti-inflammatory
    • 6.1.3. Parasiticides
    • 6.1.4. Others
  • 6.2. Market Analysis, Insights and Forecast - By Animal Type
    • 6.2.1. Companion
      • 6.2.1.1. Feline
      • 6.2.1.2. Canine
      • 6.2.1.3. Avian
      • 6.2.1.4. Others
    • 6.2.2. Livestock
      • 6.2.2.1. Poultry
      • 6.2.2.2. Porcine
      • 6.2.2.3. Bovine
      • 6.2.2.4. Others
  • 6.3. Market Analysis, Insights and Forecast - By Route of Administration
    • 6.3.1. Oral
    • 6.3.2. Parenteral
    • 6.3.3. Topical
    • 6.3.4. Aerosol
  • 6.4. Market Analysis, Insights and Forecast - By Distribution Channel
    • 6.4.1. Veterinary Hospitals
    • 6.4.2. Veterinary Clinics
    • 6.4.3. Pharmacies & Drug Stores
    • 6.4.4. Others
  • 6.5. Market Analysis, Insights and Forecast - By Country
    • 6.5.1. U.S.
    • 6.5.2. Canada

7. Europe Veterinary Drugs Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Product
    • 7.1.1. Anti-infectives
    • 7.1.2. Anti-inflammatory
    • 7.1.3. Parasiticides
    • 7.1.4. Others
  • 7.2. Market Analysis, Insights and Forecast - By Animal Type
    • 7.2.1. Companion
      • 7.2.1.1. Feline
      • 7.2.1.2. Canine
      • 7.2.1.3. Avian
      • 7.2.1.4. Others
    • 7.2.2. Livestock
      • 7.2.2.1. Poultry
      • 7.2.2.2. Porcine
      • 7.2.2.3. Bovine
      • 7.2.2.4. Others
  • 7.3. Market Analysis, Insights and Forecast - By Route of Administration
    • 7.3.1. Oral
    • 7.3.2. Parenteral
    • 7.3.3. Topical
    • 7.3.4. Aerosol
  • 7.4. Market Analysis, Insights and Forecast - By Distribution Channel
    • 7.4.1. Veterinary Hospitals
    • 7.4.2. Veterinary Clinics
    • 7.4.3. Pharmacies & Drug Stores
    • 7.4.4. Others
  • 7.5. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 7.5.1. Germany
    • 7.5.2. U.K.
    • 7.5.3. France
    • 7.5.4. Italy
    • 7.5.5. Spain
    • 7.5.6. Scandinavia
    • 7.5.7. Rest of Europe

8. Asia Pacific Veterinary Drugs Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Product
    • 8.1.1. Anti-infectives
    • 8.1.2. Anti-inflammatory
    • 8.1.3. Parasiticides
    • 8.1.4. Others
  • 8.2. Market Analysis, Insights and Forecast - By Animal Type
    • 8.2.1. Companion
      • 8.2.1.1. Feline
      • 8.2.1.2. Canine
      • 8.2.1.3. Avian
      • 8.2.1.4. Others
    • 8.2.2. Livestock
      • 8.2.2.1. Poultry
      • 8.2.2.2. Porcine
      • 8.2.2.3. Bovine
      • 8.2.2.4. Others
  • 8.3. Market Analysis, Insights and Forecast - By Route of Administration
    • 8.3.1. Oral
    • 8.3.2. Parenteral
    • 8.3.3. Topical
    • 8.3.4. Aerosol
  • 8.4. Market Analysis, Insights and Forecast - By Distribution Channel
    • 8.4.1. Veterinary Hospitals
    • 8.4.2. Veterinary Clinics
    • 8.4.3. Pharmacies & Drug Stores
    • 8.4.4. Others
  • 8.5. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 8.5.1. China
    • 8.5.2. Japan
    • 8.5.3. India
    • 8.5.4. Australia
    • 8.5.5. Southeast Asia
    • 8.5.6. Rest of Asia Pacific

9. Latin America Veterinary Drugs Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Product
    • 9.1.1. Anti-infectives
    • 9.1.2. Anti-inflammatory
    • 9.1.3. Parasiticides
    • 9.1.4. Others
  • 9.2. Market Analysis, Insights and Forecast - By Animal Type
    • 9.2.1. Companion
      • 9.2.1.1. Feline
      • 9.2.1.2. Canine
      • 9.2.1.3. Avian
      • 9.2.1.4. Others
    • 9.2.2. Livestock
      • 9.2.2.1. Poultry
      • 9.2.2.2. Porcine
      • 9.2.2.3. Bovine
      • 9.2.2.4. Others
  • 9.3. Market Analysis, Insights and Forecast - By Route of Administration
    • 9.3.1. Oral
    • 9.3.2. Parenteral
    • 9.3.3. Topical
    • 9.3.4. Aerosol
  • 9.4. Market Analysis, Insights and Forecast - By Distribution Channel
    • 9.4.1. Veterinary Hospitals
    • 9.4.2. Veterinary Clinics
    • 9.4.3. Pharmacies & Drug Stores
    • 9.4.4. Others
  • 9.5. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 9.5.1. Brazil
    • 9.5.2. Mexico
    • 9.5.3. Rest of Latin America

10. Middle East & Africa Veterinary Drugs Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Product
    • 10.1.1. Anti-infectives
    • 10.1.2. Anti-inflammatory
    • 10.1.3. Parasiticides
    • 10.1.4. Others
  • 10.2. Market Analysis, Insights and Forecast - By Animal Type
    • 10.2.1. Companion
      • 10.2.1.1. Feline
      • 10.2.1.2. Canine
      • 10.2.1.3. Avian
      • 10.2.1.4. Others
    • 10.2.2. Livestock
      • 10.2.2.1. Poultry
      • 10.2.2.2. Porcine
      • 10.2.2.3. Bovine
      • 10.2.2.4. Others
  • 10.3. Market Analysis, Insights and Forecast - By Route of Administration
    • 10.3.1. Oral
    • 10.3.2. Parenteral
    • 10.3.3. Topical
    • 10.3.4. Aerosol
  • 10.4. Market Analysis, Insights and Forecast - By Distribution Channel
    • 10.4.1. Veterinary Hospitals
    • 10.4.2. Veterinary Clinics
    • 10.4.3. Pharmacies & Drug Stores
    • 10.4.4. Others
  • 10.5. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 10.5.1. GCC
    • 10.5.2. South Africa
    • 10.5.3. Rest of Middle East & Africa

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2026)
  • 11.2. Company Profiles
    • 11.2.1. Zoetis Services LLC
      • 11.2.1.1. Overview
      • 11.2.1.2. Products
      • 11.2.1.3. SWOT Analysis
      • 11.2.1.4. Recent Developments
      • 11.2.1.5. Strategies
      • 11.2.1.6. Financials (Based on Availability)
    • 11.2.2. Merck & Co., Inc.
      • 11.2.2.1. Overview
      • 11.2.2.2. Products
      • 11.2.2.3. SWOT Analysis
      • 11.2.2.4. Recent Developments
      • 11.2.2.5. Strategies
      • 11.2.2.6. Financials (Based on Availability)
    • 11.2.3. Elanco Animal Health Incorporated
      • 11.2.3.1. Overview
      • 11.2.3.2. Products
      • 11.2.3.3. SWOT Analysis
      • 11.2.3.4. Recent Developments
      • 11.2.3.5. Strategies
      • 11.2.3.6. Financials (Based on Availability)
    • 11.2.4. Boehringer Ingelheim International GmbH.
      • 11.2.4.1. Overview
      • 11.2.4.2. Products
      • 11.2.4.3. SWOT Analysis
      • 11.2.4.4. Recent Developments
      • 11.2.4.5. Strategies
      • 11.2.4.6. Financials (Based on Availability)
    • 11.2.5. Ceva
      • 11.2.5.1. Overview
      • 11.2.5.2. Products
      • 11.2.5.3. SWOT Analysis
      • 11.2.5.4. Recent Developments
      • 11.2.5.5. Strategies
      • 11.2.5.6. Financials (Based on Availability)
    • 11.2.6. Vetoquinol
      • 11.2.6.1. Overview
      • 11.2.6.2. Products
      • 11.2.6.3. SWOT Analysis
      • 11.2.6.4. Recent Developments
      • 11.2.6.5. Strategies
      • 11.2.6.6. Financials (Based on Availability)
    • 11.2.7. Dechra Pharmaceuticals Limited
      • 11.2.7.1. Overview
      • 11.2.7.2. Products
      • 11.2.7.3. SWOT Analysis
      • 11.2.7.4. Recent Developments
      • 11.2.7.5. Strategies
      • 11.2.7.6. Financials (Based on Availability)
    • 11.2.8. Virbac Corporation
      • 11.2.8.1. Overview
      • 11.2.8.2. Products
      • 11.2.8.3. SWOT Analysis
      • 11.2.8.4. Recent Developments
      • 11.2.8.5. Strategies
      • 11.2.8.6. Financials (Based on Availability)

List of Tables

  • Table 1: Global Veterinary Drug Market Revenue (USD billion) Forecast, by Product, 2019-2032
  • Table 2: Global Veterinary Drug Market Revenue (USD billion) Forecast, by Animal Type, 2019-2032
  • Table 3: Global Veterinary Drug Market Revenue (USD billion) Forecast, by Companion, 2019-2032
  • Table 4: Global Veterinary Drug Market Revenue (USD billion) Forecast, by Livestock, 2019-2032
  • Table 5: Global Veterinary Drug Market Revenue (USD billion) Forecast, by Route of Administration 2019-2032
  • Table 6: Global Veterinary Drug Market Revenue (USD billion) Forecast, by Distribution Channel 2019-2032
  • Table 7: Global Veterinary Drug Market Revenue (USD billion) Forecast, by Region, 2021-2034
  • Table 8: North America Veterinary Drug Market Revenue (USD billion) Forecast, by Product, 2019-2032
  • Table 9: North America Veterinary Drug Market Revenue (USD billion) Forecast, by Animal Type, 2019-2032
  • Table 10: North America Veterinary Drug Market Revenue (USD billion) Forecast, by Companion, 2019-2032
  • Table 11: North America Veterinary Drug Market Revenue (USD billion) Forecast, by Livestock, 2019-2032
  • Table 12: North America Veterinary Drug Market Revenue (USD billion) Forecast, by Route of Administration 2019-2032
  • Table 13: North America Veterinary Drug Market Revenue (USD billion) Forecast, by Distribution Channel 2019-2032
  • Table 14: North America Veterinary Drug Market Revenue (USD billion) Forecast, By Country, 2021-2034
  • Table 15: Europe Veterinary Drug Market Revenue (USD billion) Forecast, by Product, 2019-2032
  • Table 16: Europe Veterinary Drug Market Revenue (USD billion) Forecast, by Animal Type, 2019-2032
  • Table 17: Europe Veterinary Drug Market Revenue (USD billion) Forecast, by Companion, 2019-2032
  • Table 18: Europe Veterinary Drug Market Revenue (USD billion) Forecast, by Livestock, 2019-2032
  • Table 19: Europe Veterinary Drug Market Revenue (USD billion) Forecast, by Route of Administration 2019-2032
  • Table 20: Europe Veterinary Drug Market Revenue (USD billion) Forecast, by Distribution Channel 2019-2032
  • Table 21: Europe Veterinary Drug Market Revenue (USD billion) Forecast, By Country/ Sub-Region, 2021-2034
  • Table 22: Asia Pacific Veterinary Drug Market Revenue (USD billion) Forecast, by Product, 2019-2032
  • Table 23: Asia Pacific Veterinary Drug Market Revenue (USD billion) Forecast, by Animal Type, 2019-2032
  • Table 24: Asia Pacific Veterinary Drug Market Revenue (USD billion) Forecast, by Companion, 2019-2032
  • Table 25: Asia Pacific Veterinary Drug Market Revenue (USD billion) Forecast, by Livestock, 2019-2032
  • Table 26: Asia Pacific Veterinary Drug Market Revenue (USD billion) Forecast, by Route of Administration 2019-2032
  • Table 27: Asia Pacific Veterinary Drug Market Revenue (USD billion) Forecast, by Distribution Channel 2019-2032
  • Table 28: Asia Pacific Veterinary Drug Market Revenue (USD billion) Forecast, By Country/ Sub-Region, 2021-2034
  • Table 29: Latin America Veterinary Drug Market Revenue (USD billion) Forecast, by Product, 2019-2032
  • Table 30: Latin America Veterinary Drug Market Revenue (USD billion) Forecast, by Animal Type, 2019-2032
  • Table 31: Latin America Veterinary Drug Market Revenue (USD billion) Forecast, by Companion, 2019-2032
  • Table 32: Latin America Veterinary Drug Market Revenue (USD billion) Forecast, by Livestock, 2019-2032
  • Table 33: Latin America Veterinary Drug Market Revenue (USD billion) Forecast, by Route of Administration 2019-2032
  • Table 34: Latin America Veterinary Drug Market Revenue (USD billion) Forecast, by Distribution Channel 2019-2032
  • Table 35: Latin America Veterinary Drug Market Revenue (USD billion) Forecast, By Country/ Sub-Region, 2021-2034
  • Table 36: Middle East & Africa Veterinary Drug Market Revenue (USD billion) Forecast, by Product, 2019-2032
  • Table 37: Middle East & Africa Veterinary Drug Market Revenue (USD billion) Forecast, by Animal Type, 2019-2032
  • Table 38: Middle East & Africa Veterinary Drug Market Revenue (USD billion) Forecast, by Companion, 2019-2032
  • Table 39: Middle East & Africa Veterinary Drug Market Revenue (USD billion) Forecast, by Livestock, 2019-2032
  • Table 40: Middle East & Africa Veterinary Drug Market Revenue (USD billion) Forecast, by Route of Administration 2019-2032
  • Table 41: Middle East & Africa Veterinary Drug Market Revenue (USD billion) Forecast, by Distribution Channel 2019-2032
  • Table 42: Middle East & Africa Veterinary Drug Market Revenue (USD billion) Forecast, By Country/ Sub-Region, 2021-2034

List of Figures

  • Figure 1: Global Veterinary Drug Market Revenue Breakdown (USD billion, %) by Region, 2026-2034
  • Figure 2: Global Veterinary Drug Market Value Share (%), by Product, 2026-2034
  • Figure 3: Global Veterinary Drug Market Value Share (%), by Animal Type, 2026-2034
  • Figure 4: Global Veterinary Drug Market Value Share (%), by Route of Administration, 2026-2034
  • Figure 5: Global Veterinary Drug Market Value Share (%), by Distribution Channel, 2026-2034
  • Figure 6: Global Veterinary Drug Market Value (USD billion), by Region, 2026-2034
  • Figure 7: North America Veterinary Drug Market Value (USD billion), by Product, 2026-2034
  • Figure 8: North America Veterinary Drug Market Value Share (%), by Product, 2026
  • Figure 9: North America Veterinary Drug Market Value (USD billion), by Animal Type, 2026-2034
  • Figure 10: North America Veterinary Drug Market Value Share (%), by Animal Type, 2026
  • Figure 11: North America Veterinary Drug Market Value (USD billion), by Route of Administration, 2026-2034
  • Figure 14: North America Veterinary Drug Market Value Share (%), by Route of Administration, 2026
  • Figure 13: North America Veterinary Drug Market Value (USD billion), by Distribution Channel, 2026-2034
  • Figure 14: North America Veterinary Drug Market Value Share (%), by Distribution Channel, 2026
  • Figure 15: North America Veterinary Drug Market Value (USD billion), By Country, 2026-2034
  • Figure 16: North America Veterinary Drug Market Value Share (%), By Country, 2026
  • Figure 17: Europe Veterinary Drug Market Value (USD billion), by Product, 2026-2034
  • Figure 18: Europe Veterinary Drug Market Value Share (%), by Product, 2026
  • Figure 19: Europe Veterinary Drug Market Value (USD billion), by Animal Type, 2026-2034
  • Figure 20: Europe Veterinary Drug Market Value Share (%), by Animal Type, 2026
  • Figure 21: Europe Veterinary Drug Market Value (USD billion), by Route of Administration, 2026-2034
  • Figure 22: Europe Veterinary Drug Market Value Share (%), by Route of Administration, 2026
  • Figure 23: Europe Veterinary Drug Market Value (USD billion), by Distribution Channel, 2026-2034
  • Figure 24: Europe Veterinary Drug Market Value Share (%), by Distribution Channel, 2026
  • Figure 25: Europe Veterinary Drug Market Value (USD billion), By Country/Sub-Region, 2026-2034
  • Figure 26: Europe Veterinary Drug Market Value Share (%), By Country/Sub-Region, 2026
  • Figure 27: Asia Pacific Veterinary Drug Market Value (USD billion), by Product, 2026-2034
  • Figure 28: Asia Pacific Veterinary Drug Market Value Share (%), by Product, 2026
  • Figure 29: Asia Pacific Veterinary Drug Market Value (USD billion), by Animal Type, 2026-2034
  • Figure 30: Asia Pacific Veterinary Drug Market Value Share (%), by Animal Type, 2026
  • Figure 31: Asia Pacific Veterinary Drug Market Value (USD billion), by Route of Administration, 2026-2034
  • Figure 32: Asia Pacific Veterinary Drug Market Value Share (%), by Route of Administration, 2026
  • Figure 33: Asia Pacific Veterinary Drug Market Value (USD billion), by Distribution Channel, 2026-2034
  • Figure 34: Asia Pacific Veterinary Drug Market Value Share (%), by Distribution Channel, 2026
  • Figure 35: Asia Pacific Veterinary Drug Market Value (USD billion), By Country/Sub-Region, 2026-2034
  • Figure 36: Asia Pacific Veterinary Drug Market Value Share (%), By Country/Sub-Region, 2026
  • Figure 37: Latin America Veterinary Drug Market Value (USD billion), by Product, 2026-2034
  • Figure 38: Latin America Veterinary Drug Market Value Share (%), by Product, 2026
  • Figure 39: Latin America Veterinary Drug Market Value (USD billion), by Animal Type, 2026-2034
  • Figure 40: Latin America Veterinary Drug Market Value Share (%), by Animal Type, 2026
  • Figure 41: Latin America Veterinary Drug Market Value (USD billion), by Route of Administration, 2026-2034
  • Figure 42: Latin America Veterinary Drug Market Value Share (%), by Route of Administration, 2026
  • Figure 43: Latin America Veterinary Drug Market Value (USD billion), by Distribution Channel, 2026-2034
  • Figure 44: Latin America Veterinary Drug Market Value Share (%), by Distribution Channel, 2026
  • Figure 45: Latin America Veterinary Drug Market Value (USD billion), By Country/Sub-Region, 2026-2034
  • Figure 46: Latin America Veterinary Drug Market Value Share (%), By Country/Sub-Region, 2026
  • Figure 47: Middle East & Africa Veterinary Drug Market Value (USD billion), by Product, 2026-2034
  • Figure 48: Middle East & Africa Veterinary Drug Market Value Share (%), by Product, 2026
  • Figure 49: Middle East & Africa Veterinary Drug Market Value (USD billion), by Animal Type, 2026-2034
  • Figure 50: Middle East & Africa Veterinary Drug Market Value Share (%), by Animal Type, 2026
  • Figure 51: Middle East & Africa Veterinary Drug Market Value (USD billion), by Route of Administration, 2026-2034
  • Figure 52: Middle East & Africa Veterinary Drug Market Value Share (%), by Route of Administration, 2026
  • Figure 53: Middle East & Africa Veterinary Drug Market Value (USD billion), by Distribution Channel, 2026-2034
  • Figure 54: Middle East & Africa Veterinary Drug Market Value Share (%), by Distribution Channel, 2026
  • Figure 55: Middle East & Africa Veterinary Drug Market Value (USD billion), By Country/Sub-Region, 2026-2034
  • Figure 56: Middle East & Africa Veterinary Drug Market Value Share (%), By Country/Sub-Region, 2026
  • Figure 57: Global Veterinary Drug Market Share (%), By Company, 2026